A recently published NACDS Foundation research project underscores the power of public health and community-based, pharmacy partnerships when it comes to tackling critical health priorities and improving patient health outcomes.
March 1 Forum in Washington, D.C. advances collaborative role of pharmacy; continues momentum of “NACDS 2023” focus on adding value to members’ innovation of health and wellness in the pharmacy and beyond.
NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:
Pharmacy benefit manager (PBM) reform; comprehensive direct and indirect remuneration (DIR) fee reform; and sustaining patient access to vaccinations, testing, and treatment among key topics at the February 28-March 1 program.
U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen.
Statement reflects “NACDS 2023” focus on adding value to NACDS members’ innovation of health and wellness in the pharmacy and beyond.
Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings.
Dinner’s new venue in 25th Anniversary year will continue to build visibility and engagement for the NACDS Foundation’s focus on “cultivating innovation in care”.
Statement outlines specific solutions to patient-manipulation by “PBMs”.
NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule.
